Tiziana Life Sciences Acquires a Nanoparticle-Based Formulation Technology for Controlled Delivery of Actinomycin D for Treatment of Myelodysplastic syndrome and Acute Myeloid Leukemia

Nanoparticle Actinomycin formulation minimizes toxicity and enhances tolerability by slow release of drug to control Cmax in blood This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. NEW YORK and LONDON, United Kingdom, April 24, 2020 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq: […]

BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates

First COVID-19-related clinical trial to start in Germany Initial dose escalation phase to target dose range of 1µg to 100µg Clinical supply from BioNTech’s GMP-certified mRNA production facilities in Europe Four vaccine candidates to enter clinical development       MAINZ, Germany and NEW YORK, April 22, 2020 (GLOBE NEWSWIRE) — BioNTech SE […]

Sense Appoints John Bishop to its Board of Directors

Former Cepheid CEO joins as company launches an accelerated program for the world’s first instrument-free molecular test for COVID-19 CAMBRIDGE and OXFORD, UNITED KINGDOM, April 21, 2020 (GLOBE NEWSWIRE) — Sense Biodetection Limited (Sense) has today announced the appointment of John Bishop as non-executive director.  John was the Chief Executive […]

MedMira gibt ein Update zur Entwicklung eines Point-of-Care-Antikörpertests bekannt

HALIFAX, Nova Scotia, April 20, 2020 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), hat heute bekanntgegeben, dass es die Entwicklung einer serologischen Point-of-Care-(POC)-Testlösung mit sofort bereitstehendem Ergebnis abgeschlossen hat. Basierend auf der einzigartigen und patentierten Rapid Vertical Flow®-(RVF)-Technologie von MedMira liefert der neu entwickelte REVEALCOVID-19™ sofortige Ergebnisse, ohne dass zusätzliche […]

MedMira Announces Update on Development of Point-of-Care Antibody Test

HALIFAX, Nova Scotia, April 17, 2020 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), announced today that it has completed the development of the serological Point-of-Care (POC) testing solution with immediate result. Based on MedMira’s unique and patented Rapid Vertical Flow® (RVF) technology, the newly developed REVEALCOVID-19TM delivers immediate results […]

BioNTech und Pfizer geben weitere Details zur Kollaboration bekannt, um globale COVID-19-Impfstoffentwicklung voranzutreiben

Pfizer und BioNTech entwickeln gemeinsam einen Impfstoff gegen COVID-19, zunächst in den USA und Europa, und erhöhen die Produktionskapazitäten zur Unterstützung der globalen Versorgung Potenzial zur Herstellung von Millionen an Impfstoffdosen bis Ende 2020, vorbehaltlich des technischen Erfolgs des Entwicklungsprogramms und der Genehmigung durch die Behörden, sowie rascher Ausbau der […]

Tiziana Lifesciences Develops Novel Investigational Treatment For Patients Infected with COVID-19 Utilizing Direct Delivery of Anti-Interlukin-6-Receptor Monoclonal Antibodies

NEW YORK and LONDON, April 09, 2020 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for inflammatory and autoimmune diseases, announced today that it has developed investigational new technology to treat COVID-19 infections, which consists of direct delivery […]